Abstract
We report on a patient with phenylketonuria who developed disabling extrapyramidal features that were successfully controlled with L-dopa. We recommend that all such patients are given a trial with this drug.
Cite
CITATION STYLE
APA
Macleod, M. D., Munro, J. F., Ledingham, J. G., & Farquhar, J. W. (1983). Management of the extrapyramidal manifestations of phenylketonuria with L-dopa. Archives of Disease in Childhood, 58(6), 457–458. https://doi.org/10.1136/adc.58.6.457
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free